Journal article
Sarcolemmal ATP-sensitive K+ channels control energy expenditure determining body weight
Cell metabolism, Vol.11(1), pp.58-69
01/2010
DOI: 10.1016/j.cmet.2009.11.009
PMCID: PMC2849280
PMID: 20074528
Abstract
Metabolic processes that regulate muscle energy use are major determinants of bodily energy balance. Here we find that sarcolemmal ATP-sensitive K
+
(K
ATP
) channels, which couple membrane excitability with cellular metabolic pathways, set muscle energy expenditure under physiological stimuli. Disruption of K
ATP
channel function provoked, in conditions of unaltered locomotor activity and blood substrate availability, an extra energy cost of cardiac and skeletal muscle performance. Inefficient fuel metabolism in K
ATP
channel-deficient striated muscles reduced glycogen and fat body depots promoting a lean phenotype. The propensity to lesser body weight imposed by K
ATP
channel deficit persisted under a high-fat diet, yet obesity restriction was achieved at the cost of compromised physical endurance. Thus, sarcolemmal K
ATP
channels govern muscle energy economy, and their down-regulation in a tissue-specific manner could present an anti-obesity strategy by rendering muscle increasingly thermogenic at rest and less fuel efficient during exercise.
Details
- Title: Subtitle
- Sarcolemmal ATP-sensitive K+ channels control energy expenditure determining body weight
- Creators
- Alexey E Alekseev - Marriott Heart Diseases Research Program, Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics and Department of Medical Genetics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USASantiago Reyes - Marriott Heart Diseases Research Program, Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics and Department of Medical Genetics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USASatsuki Yamada - Marriott Heart Diseases Research Program, Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics and Department of Medical Genetics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USADenice M Hodgson-Zingman - Marriott Heart Diseases Research Program, Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics and Department of Medical Genetics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USASrinivasan Sattiraju - Marriott Heart Diseases Research Program, Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics and Department of Medical Genetics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USAZhiyong Zhu - Department of Internal Medicine, University of Iowa, Carver College of Medicine, 285 Newton Rd., CBRB2296, Iowa City, Iowa 52242 USAAna Sierra - Department of Internal Medicine, University of Iowa, Carver College of Medicine, 285 Newton Rd., CBRB2296, Iowa City, Iowa 52242 USAMarina Gerbin - Marriott Heart Diseases Research Program, Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics and Department of Medical Genetics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USAWilliam A Coetzee - Department of Pediatrics, NYU School of Medicine, 560 First Avenue TCH-521, New York, New York 10016, USADavid J Goldhamer - The Center for Regenerative Biology, Department of Molecular and Cell Biology, Advanced Technology Laboratory, University of Connecticut, 1392 Storrs Road Unit 4243, Storrs, Connecticut 06269, USAAndre Terzic - Marriott Heart Diseases Research Program, Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics and Department of Medical Genetics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USALeonid V Zingman - Marriott Heart Diseases Research Program, Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics and Department of Medical Genetics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
- Resource Type
- Journal article
- Publication Details
- Cell metabolism, Vol.11(1), pp.58-69
- DOI
- 10.1016/j.cmet.2009.11.009
- PMID
- 20074528
- PMCID
- PMC2849280
- ISSN
- 1550-4131
- eISSN
- 1932-7420
- Language
- English
- Date published
- 01/2010
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Cardiovascular Medicine; Internal Medicine
- Record Identifier
- 9984094372102771
Metrics
19 Record Views